Since any compound of Formula I wherein Z is a group of Formula a or c wherein R11 is a cation other than M may be converted into the corresponding compound wherein R11 is hydrogen, M or R12 by the processes of Reaction Schemes V and VI, the compounds of Formula I wherein Z is a group of Formula a or c and R11 is a pharmaceutically unacceptable cation are also within the scope of this invention si